NIMH SBIR/STTR
Supports small United States businesses developing mental health products and digital therapeutics.
NIMH SBIR/STTR sits under the NIH small business program at the National Institute of Mental Health. It is the institute's route for U.S. small businesses building mental-health products, including digital therapeutics, diagnostics, assessment tools, intervention platforms, and related biomedical devices. The mechanisms are R43/R44 for SBIR and R41/R42 for STTR. Solicitations issue multiple times per year across NIMH priority topic areas, and applicants are asked to send a brief abstract at least one month before the standard deadline. The eligibility profile is narrow: for-profit firms are required, nonprofits, universities, research organisations, and individuals are not. The funding pages group this route with opportunities and announcements, grant writing and approval, managing grants, clinical research, training, and small business research. The landing page also notes that some content is not updated regularly during current HHS and NIH restructuring, so applicants should work from the current solicitation and program officer guidance rather than older pages.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds United States small businesses commercializing biomedical technologies after an NIH SBIR or STTR Phase II award.
Supports United States. small businesses building mental health technologies through recurring NIH pathways.